KRTX - GSK looking to boost pipeline with respiratory auto-immune deals - report
2023-12-26 11:28:36 ET
More on GSK
- AbbVie Vs. GSK: Dual Dominance In Pharma
- GSK - Greenshoots In The Horizon
- Getting_Ahead_of_Respiratory_Diseases_Slides
- EU regulators recommend against renewing approval for GSK's Blenrep
- AbbVie, AstraZeneca targeted for improper use of drug patents
For further details see:
GSK looking to boost pipeline with respiratory, auto-immune deals - report